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Abstract
Cooperation between receptors allows integrated intracellular signaling leading to appropriate physiological responses. The
Neural Cell Adhesion Molecule (NCAM) has three main isoforms of 120, 140 and 180 kDa, with adhesive and signaling
properties, but their respective functions remains to be fully identified. Here we show that the human NCAM180
intracellular domain is a novel interactor of the human guanosine exchange factor (GEF) Ric8A using the yeast two hybrid
system and immunoprecipitation. Furthermore, NCAM, Ric8A and Gas form a tripartite complex. Colocalization experiments
by confocal microscopy revealed that human NCAM180 specifically induces the recruitment of Ric8A to the membrane. In
addition, using an in vitro recombinant system, and in vivo by comparing NCAM knock-out mouse brain to NCAM
heterozygous and wild type brains, we show that NCAM expression dose dependently regulates Ric8A redistribution in
detergent resistent membrane microdomains (DRM). Previous studies have demonstrated essential roles for Ric8 in Ga
protein activity at G protein coupled receptors (GPCR), during neurotransmitter release and for asymmetric cell division. We
observed that inhibition of Ric8A by siRNA or its overexpression, decreases or increases respectively, cAMP production
following b-adrenergic receptor stimulation. Furthermore, in human HEK293T recombinant cells, NCAM180 potentiates the
Gas coupled b-adrenergic receptor response, in a Ric8A dependent manner, whereas NCAM120 or NCAM140 do not. Finally,
in mouse hippocampal neurons expressing endogenously NCAM, NCAM is required for the agonist isoproterenol to induce
cAMP production, and this requirement depends on Ric8A. These data illustrate a functional crosstalk between a GPCR and
an IgCAM in the nervous system.
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Introduction
NCAM comprises three major alternatively spliced isoforms [1].
While their extracellular domains are identical, NCAM180 has a
267 amino acid insert in the intracellular domain compared to
NCAM140, and NCAM120 is glycophosphatidylinositol (GPI)-
anchored at the membrane. However, the specialized functions of
each NCAM isoform and their respective interacting partners
remain incompletely elucidated. NCAM mediates a variety of cell–
cell interactions important for neural development, synapse
formation and synaptic plasticity. Some of these effects may be
attributable to NCAM acting as a cell adhesion molecule whereas
others result from a complex network of intracellular signaling
cascades [2–4]. As the signal transduction of extracellular cues
depends on multimolecular receptor complexes and modulators of
intracellular effectors, it is anticipated that interactions and
cooperative mechanisms exist between NCAM isoforms and
proteins with previously unsuspected related functions.
Seven transmembrane G protein coupled receptors (GPCR),
coupled to Gabc proteins, have been characterized extensively and
generate responses to a wide range of stimuli in physiological or
diseased conditions. The equilibrium between the inactive and
active Ga is modulated by GTPase activating proteins, non-
receptor GEFs, and Guanine dissociation inhibitors [5]. The Ric8
family has two known members, Ric8B and the evolutionary
conserved Ric8A. In mammals, Ric8A acts broadly on monomeric
Ga proteins [6]. In Drosophila [7,8] as in Caenorhabditis elegans
(C.elegans) [9] or mammalian cells [10], Ric8A is critical to
asymetric cell divisions. Interestingly, C. elegans Ric8A knock out is
defective in neurotransmitter secretion and in synaptic vesicle
priming [11]. The resulting paralysis phenotype can be rescued by
genes of the Gaq and Gas pathways [12].
Overlapping functions of Ric8A, NCAM180 and b-adrenergic
receptors have been described in neurotransmitter release [11,13–
15], or mouse behavioral phenotypes [16–19]. Here, we demon-
strate that these 3 molecules are functionally linked, hence tying a
cell adhesion molecule to GPCR signaling in the nervous system.
Materials and Methods
Ethics
Animals weretreated according to guidelinesofthe Frenchethical
committee who approved the study (approval ID: E13-055-21).
Yeast two-hybrid screening
Yeasttwo-hybridscreeningwasperformedusingthe ProQuest
TM
system (Invitrogen). The complete coding region of human
NCAM180 and NCAM140 intracellular domains (NCAM180cyto
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plasmids containing each full lenght NCAM isoforms [20], and
subcloned into a pDONR221 plasmid using GatewayH Technology
(Invitrogen). Recombination with pDEST32 plasmid generated
the yeast bait constructs DNA-Binding (DB)-NCAM180cyto and
DB-NCAM140cyto. The prey corresponded to the human adult
brain ProQuest cDNA library fused to the GAL4 activation domain
in the pEXP-AD22 plasmid. Yeast MaV203 competent cells were
co-transformed by the library and DB-NCAM180cyto or DB-
NCAM140cyto. Positive clones from screening were sequenced
(Eurofins MWG Operon) and identified using BLAST analysis.
Antibodies, immunoprecipitation and GST-pull down
Purified full lenght Ric8A-GST was used to produce a rat anti-
Ric8A antibody (Eurogentec). A goat polyclonal NCAM antibody
was produced (Eurogentec) using immunopurified mouse of either
sex brain NCAM. For immunopurification, H28 anti-NCAM
monoclonal antibody [21] was covalently coupled to Aminolink
beads (Pierce) (10 mg antibody/ml resin). Purification of IgG
fractions from anti-Ric8A and anti-NCAM sera was performed
using protein G beads (Pierce). The specificity of the anti-NCAM
antibody was assessed on NCAM knock out brain extract for
which no signal was detected and HEK293T cells transfected with
each NCAM isoform (not shown). The antibody was able to detect
all three NCAM isoforms.
For immunoprecipitation, anti-NCAM was immobilized on
aldehyde activated AminoLink beads. Control beads were
AminoLink beads quenched with 1 M TrisHCl. Anti-NCAM
beads were incubated with female mouse brain or HEK293T cells
extracts in PBS+0.1% Nonidet P-40 (NP-40) (overnight, 4uC),
washed 3 times with PBS, and bound proteins eluted with b-
mercaptoethanol containing Laemli buffer.
For GST-pull down, female mouse brain extract was cleared
with GSH beads (1 h, 4uC). The cleared lysate was incubated with
recombinant Ric8A-GST (3 h, RT). GSH beads were added to
this mixture (1 h, 4uC). The beads were washed, bound proteins
eluted as above, and NCAM detected by Western blot. Control
beads consisted of GSH beads incubated with purified GST and
cleared lysate. Rat anti-Ric8A (1:4000), anti-NCAM (1:3000),
anti-caveolin3 (1:2000; Abcys), and rabbit anti-Gas antibody (K20,
1:500; Ozyme) were used.
Immunofluorescence
Neurons transfected with Ric8A-GFP, or HEK293T cells co-
transfected with Ric8A-GFP and NCAM120, NCAM140 or
NCAM180 were fixed after 24 h with 4% parafomaldehyde and
stained with goat polyclonal anti-NCAM (1:1000, 2 h, RT)
followed by Alexa555-anti-goat antibody (1:500, 1 h, RT, Jackson
Laboratory). Confocal images were obtained using a LSM510
Meta UV microscope (Zeiss).
Inhibition of Ric8A by RNA interference
Inhibition of endogenous Ric8A in HEK293T cells and neurons
was performed using human and mouse Ric8A pools of siRNA
(OnTarget Smart pools, Thermo Fisher Scientific Dharmacon)
designed to have no off-target effects [22]. The target sequences
are GGGGAGAUGCUCGGAACA, AGAACUUUCCAUACG-
AGUA, CAGGAUGCCAUGUGCGAGA and CAGAGGAGU-
UCCACGGCCA for human Ric8A and GAGAGUAGCUGCC-
GAGUUC, GUGUGGGACUGUACCGCAA, GUACACAG-
GCUACGGGAAU and CAGAGGAGUUCCACGGCCA for
mouse Ric8A.
The efficiency of inhibition was verified in COS-7 cells transfected
with human Ric8A-GFP, and in HEK293T cells transfected or not
with NCAM180 (Suppl Fig. S1). SiGLO RNA-induced silencing
complex-free control siRNA, a fluorescent siRNA without RNA
target (Thermo Fisher Scientific Dharmacon) was used as control
siRNA in all experiments (siCtrl). The sequences of Ric8A siRNA
had no homology with Ric-8B, therefore could not inhibit Ric8B
transcription. Transfections of siRNA (0.1 nmol per 10
6 cells) were
performed using the Amaxa electroporation system (kit V for
HEK293T cells and mouse neuron nucleofector kit for neurons) as
indicated by the manufacturer (Lonza).
Cell culture, cloning and transfections
All cell lines were from American Tissue Culture Collection.
COS-7 and HEK293T cells were grown in DMEM with 10%
FCS, penicillin (50 Units/ml) and streptomycin (100 mg/ml)
(Invitrogen). Mouse embryonic cortical and hippocampal neurons
were prepared as described and plated in Neurobasal medium
(NB) with B27 supplement [23]. Human Ric8A was cloned in
pDEST48-GFP, pDEST15-GST and pcDNA3-V5 tagged plas-
mid using the Gateway system procedures. The 3 full length
NCAM isoforms were in pRC/CMV [20]. Pmax-GFP (Lonza)
was used as control plasmid. Ric8A-GST was produced after
IPTG induction of DH-5a bacteria and purified on GSH-
Sepharose fast flow beads (GE Healthcare). Transfections of
plasmids (2 mg for 10
6 cells) and siRNA (0.1 nmol per 10
6 cells)
were performed using the Amaxa electroporation system (Lonza).
For PSA-NCAM-Fc production, TE671 cells, which express
polysialyltransferases [20], were transiently transfected using
lipofectamine (Invitrogen) according to the manufacturer’s in-
struction in OptiMEM medium (Invitrogen). pIG1 expression
plasmid encoding NCAM-Fc was kindly provided by Dr Simmons
(Cell Adhesion Laboratory) and previously used in our laboratory
[24]. Culture supernatants were harvested 60 h after transfection,
and Fc-bearing secreted PSA-NCAM was affinity-purified on a
protein-A column (Pierce). The affinity-isolated proteins were
analysed under reducing conditions by SDS-PAGE. The resulting
purified solution was then concentrated and buffer exchanged in
PBS using Centricons (Millipore), and adjusted to a final
concentration of 10 mg/ml.
Preparation of DSM and DRM fractions
Cells or tissue (brain from male mice) lysis was performed by
sonication of a given volume (V) of ice-cold 10 mM Tris HCl
pH 7.4 containing Complete
TM protease inhibitors (PI; Roche).
The nuclear and mitochondrial fractions, and debris were
removed by centrifugation (10000 g, 4uC, 15 min). The superna-
tant (corresponding to the cytosolic fraction) was spun down
(100000 g, 1 h, 4uC). The pellet, corresponding to the membrane
fraction, was resuspended in the initial volume V of PBS+PI+1%
NP40, and sonicated. This extract was spun down (100000 g, 1 h,
4uC). The supernatant corresponded to DSM and the pellet to
DRM. The later was sonicated in the same volume V of
PBS+PI+1% NP40. The quality of preparation of DSM and
DRM was monitored by the presence of caveolin-3 in DRM and
DSM, a criterion previously used [25,26].
b-adrenergic receptor stimulation, Phosphorylated-ERK
(P-ERK) and cAMP measurements
HEK293T cells or hippocampal neurons were transfected and
plated in 24-well plates (180000 HEK293T cells/well or 500000
neurons/well). The next day, HEK293T cells were placed in
serum free DMEM for 24 h. Neurons or HEK293T cells were
washed with HBSS containing 1 mM isobutylmethylxanthine, and
treated with isoproterenol for 20 min. Medium was removed and
NCAM180-Ric8A Interaction
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TM (R&D
Systems).
P-ERK was quantified by Western blot from hippocampal
neurons extracts (PBS+1%NP-40) after 1.5 h of culture in NB
medium, followed by 5 min 10 mM isoproterenol treatment, using
anti-actin (AC-40, 1:1000, Sigma) and anti-phopho-ERK1/2
(20G11, 1:1000; Ozyme).
Neurite outgrowth measurement
For neurite outgrowth experiments, cortical neurons were pre-
pared from embryonic stage E15–16 mouse cortex as previously
described in details for hippocampal neurons [27]. Briefly, cortices
of 6 embryos were dissected out and digested with Trypsin
(Invitrogen). The digestion was stopped by adding NB medium
supplemented with 10% FCS. After centrifugation, the tissue was
mechanically dissociated and cells counted. Neurons were cultured
in NB medium supplemented with 0.5 mM Glutamax, B27
(Invitrogen), and 25 mM L-glutamine (Sigma). 1.5610
3 cells/ml
were plated in 96-well black plates (Greiner). Coating conditions
were either 10 mg/ml poly-D-Lysine (Sigma) alone or in
combination with PSA-NCAM-Fc protein (10 mg/ml) coated
overnight after poly-D-lysine. Such cultures contained more than
95% neurons. After 3 days in culture, live cells were stained with
0.5 mg/ml green calceine-acetoxymethyl ester (Molecular Probes)
and images of the entire wells captured using a flash cytometer
(Trophos) (8 wells per condition). Neurite outgrowth was measured
using the Metamorph software (Molecular Devices).
Statistical analysis
Statistical significance was achieved for p,0.05 (*), p,0.01 (**)
and p,0.001 (***). One-way ANOVA was used when more than
2 groups were compared, followed by the Bonferroni post-hoc test.
The t-test was used when 2 groups were compared.
Results
NCAM180 interacts with Ric8A
In an attempt to identify interactors of the intracellular domains
of NCAM180 (NCAM180cyto) and NCAM140 (NCAM140cyto), a
yeast two-hydrid screen was performed using NCAM180cyto or
NCAM140cyto as baits and a human adult cDNA library as prey.
We focussed our study on the interactor Ric8A, as we found it
interacted with NCAM180cyto, but not with NCAM140cyto. One of
the Ric8A clones present in the library and positive for
NCAM180cyto, but not with NCAM140cyto covered 90% of the
Ric8A entire sequence, suggesting the specificity of the interaction
of Ric8A with NCAM180.
To further demonstrate an interaction between NCAM and
Ric8A, we performed co-immunoprecipitation experiments from
mouse brain extract. An antibody against the human recombinant
protein Ric8A-GST was generated and recognized Ric8A-GST
and a protein of 60 kDa corresponding to Ric8A in mouse brain
extract (Fig. 1A). Ric8A was detected in immunocomplexes after
immunoprecipitation from a brain extract with beads coupled to
anti-NCAM, but not with control beads (Fig. 1B). Moreover,
Ric8A-GST, but not GST control beads, pulled down NCAM180
from brain extract (Fig. 1C). Altogether, these data indicate that
the intracellular domain of NCAM180 interacts with Ric8A.
NCAM180 allows recruitment of Ric8A at the cell
membrane
To further investigate the interaction of NCAM with Ric8A, we
transfected HEK293T cells with Ric8A-GFP and the three
different NCAM isoforms. We showed by confocal imaging that
when NCAM180 was overexpressed in HEK293T cells (Fig. 2A),
Ric8A-GFP was strongly colocalized to NCAM staining at the
membrane. Similarly, in neurons transfected with Ric8A-GFP,
there was a strong colocalization between Ric8A-GFP and
endogenous NCAM at the membrane and in growth cones
(Fig. 2B). Conversely, when NCAM120 or NCAM140 was
overexpressed in HEK293T cells, Ric8A-GFP was mostly found
in the cytoplasm, and very slightly colocalized with NCAM120, or
NCAM140 at the membrane of HEK293T cells, compared to
NCAM180 (Fig. 2A). Pearson correlation coefficients for coloca-
lization in HEK293T cells were derived from the LSM Zeiss
software colocalization scatterplot coordinate system by selecting
the region of the entire membrane area, and were 0.22, 0.38 and
0.66 for NCAM120, NCAM140 and NCAM180, respectively.
Recruitment of Ric8A at the membrane by NCAM180 was
confirmed by a biochemical approach in COS-7 cells co-
transfected with V5-tagged Ric8A and NCAM180 (Fig. 3). We
performed subcellular fractionation of the cytosol, detergent
soluble (DSM) and resistent (DRM) membrane subdomains
(Fig. 3A). Total Ric8A-V5 was used as its own internal control
in each cell line. When NCAM180 was expressed, the percentage
of Ric8A-V5 present in the cytosol decreased from 68 to 43% and
increased from 32 to 57% in the total membrane fraction
(DSM+DRM). Therefore, in contrast to NCAM120 and
NCAM140, NCAM180 colocalized with Ric8A and specifically
induced trafficking of Ric8A from the cytoplasm to the membrane.
NCAM controls the presence of Ric8A in detergent
resistant membrane domains
We noticed that Ric8A distribution in the subcellular comparte-
ments DSM versus DRM was affected by NCAM180 overexpres-
sion in COS-7 cells (Fig. 3B, C). In COS-7 cells overexpressing
NCAM180, 40% of membranous Ric8A was shifted to DRM
(Fig. 3C). We used brain extracts from genetically modified
NCAM knockout mice to analyze how NCAM influenced Ric8A
distribution between DSM and DRM (Fig. 3D). Whether NCAM
was expressed or not, Ric8A was never detected in the cytosol (not
shown), suggesting that in the brain, endogenous Ric8A is
predominantly present at the membrane. We compared endog-
enous Ric8A expression in NCAM deficient (2/2), heterozygous
(+/2) and wild type (+/+) mouse brains. Total Ric8A amount was
not different between genotypes (not shown). The presence of the
marker caveolin-3 for the DRM fraction was not affected by the
Figure 1. Biochemical analysis of Ric8A-NCAM interaction. A-
Characterization of the developed rat anti-Ric8A antibody by Western
blot reveals a protein of 60 kDa, which is the expected molecular
weight for Ric8A, from a brain extract. The GST coupled to Ric8A leads
to a molecular weight of 86 kDa. B- Ric8A was immunoprecipitated
from mouse brain extract with Aminolink beads coupled to a polyclonal
anti-NCAM antibody but not with control beads. C- NCAM180 was
pulled down from a mouse brain extract containing the 120, 140 and
180 kDa NCAM isoforms by Ric8A-GST but not by control beads.
doi:10.1371/journal.pone.0032216.g001
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mice, Ric8A was exclusively found in the DRM fraction, whereas
loss of NCAM (2/2) induced a redistribution of Ric8A, which
was approximately even between the DRM (56%) and DSM
fractions (44%) (Fig. 3D, E). These data indicate that in adult wild
type mouse brain, NCAM maintains 44% of Ric8A in DRM.
Moreover, NCAM is a dose-dependent determinant of this process
since a half dose of NCAM (+/2) resulted in half of this amount
(23%) remaining localized in DSM (Fig. 3D, E).
To further elucidate whether the isoform NCAM180 had a
specific and active direct role in the translocation of Ric8A from
DSM to DRM, we used HEK293T cells expressing recombinant
NCAM140 or NCAM180. Endogenous Ric8A was exclusively
found in the membrane fraction as in mouse brain. Similar
proportions of Ric8A were present in DRM and DSM fractions in
control or NCAM140 transfected HEK293T cells. By contrast,
NCAM180 expression led to a strong prevalence of Ric8A in
DRM. Ric8A was 2.7+/20.4 (mean +/2 SD) times more
abundant in DRM than in DSM in NCAM180 expressing cells
than in control cells (p,0.01) or NCAM140 expressing cells
(p,0.05; 3 independent cultures; ANOVA, Bonferroni post-hoc
test) expression. The percentage of Ric8A translocated to DRM by
NCAM180 was 46% of total Ric8A. Altogether, these data
indicate that NCAM180 specifically induces a relocalization of
endogenous Ric8A from DSM to DRM domains.
Ric8A is not involved in PSA-NCAM induced neurite
outgrowth
The involvement of Gai/Gao coupled receptor channels in trans
homophilic NCAM stimulated neurite outgrowth has been
previously reported [28,29]. We set up to investigate whether
Ric8A could also be involved. To this end we treated cortical
neurons with soluble PSA-NCAM-Fc, which very significantly
increased neurite outgrowth. Treatment with either control siRNA
or siRic8A did not affect the stimulation of growth (Fig. 4).
Moreover, no effect of Ric8A was found on the number of
processes or their branching (not shown).
NCAM-Ric8A interaction modulates b-adrenergic
response in HEK293T cells
We further studied the functional significance of the NCAM-
Ric8A interaction by postulating that NCAM could affect GPCR
signaling in which Ric8A is known to play a GEF regulatory role.
Figure 2. NCAM180 induces Ric8A-GFP recruitement at the
membrane where NCAM and Ric8A colocalize. A- Ric8A-GFP co-
transfected with NCAM120, NCAM140 or NCAM180 in HEK293T cells co-
localizes specifically with the NCAM180 isoform. Scale bar: 10 mm. B-
Ric8A-GFP or PmaxGFP plasmids were transfected in cortical neurons
for 24 h. Images were taken focussing at the membrane plane with a
206 objective. NCAM staining is clearly associated to the cell
membrane (B, E, K). Ric8A-GFP is strongly localized at the membrane
at the level of the cell body and processes (A, D). PmaxGFP control
plasmid is mostly found in the cytoplasm (J). Ric8A-GFP, but not
PmaxGFP colocalizes with NCAM at the membrane (Ric8A/NCAM
merge: C, F versus Pmax/NCAM merge: L). (G–I): higher magnification
pictures (dotted line box D–F) using a 636 oil immersion objective
indicate a strong co-localization of Ric8A-GFP with NCAM in the growth
cone (I). Scale bars: 10 mm (A–F, J–O); 1 mm (G–I).
doi:10.1371/journal.pone.0032216.g002
Figure 3. NCAM affects Ric8A relative distribution in DSM and
DRM fractions in vitro and in vivo. A- Western blot of overexpressed
Ric8A-V5 in cytosol, DSM and DRM. B, C- Quantitative analysis of
Western blots in A. D- Western blot of Ric8A in DSM and DRM from
brain extracts prepared from NCAM null (2/2), heterozygous (+/2) and
wild type (+/+) mice. Caveolin-3, a marker for enrichment of lipid rich
domains was detected only in DRM. E- Quantitative analysis of Western
blots presented in D (n=3 per genotype). Data are expressed as mean
+/2 SEM; *p,0,05, **p,0,01, ***p,0,001. One-way ANOVA for more
than 2 groups was performed. The effect of the single factor ‘genotype’
was then analysed by the Bonferroni post-hoc test.
doi:10.1371/journal.pone.0032216.g003
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adrenergic agonist stimulation [30], we postulated that the
observed redistribution of Ric8A in DRM could also affect b-
adrenergic signaling. We used the agonist isoproterenol to target
the Gas coupled b-adrenergic receptors present in HEK293T cells.
We compared the amount of cAMP produced by 10 mM
isoproterenol in several conditions: the absence or presence of
NCAM180, the inhibition of human Ric8A by siRNA, and the
overexpression of Ric8A. Our analyses first revealed that siRic8A,
which induced an 80% decrease of Ric8A expression (Suppl Fig.
S1), inhibited cAMP production in the absence or presence of
NCAM180 (Fig. 5A). Second, when Ric8A was overexpressed in
HEK293T cells, cAMP production was dramatically increased
(Fig. 5B). This shows that Ric8A allows the potentiation of b-
adrenergic response. Unstimulated HEK293T cells had similar
levels of cAMP in all conditions (siCtrl: 0.87+/20.07 nM; siRic8:
0.40+/20.05 nM; siCtrl+NCAM180: 0.85+/20.26 nM; siRi-
c8A+NCAM180: 0.51+/20.12 nM in a representative experi-
ment out of 3 performed), indicating that NCAM does not affect
basal cAMP homeostasis and that its effect is dependent on
receptor activation. Third, Gas was immunoprecipitated by
NCAM, along with Ric8A, in a Ric8A-dependent manner
(Fig. 5C). Therefore NCAM does not directly interact with Gas,
as Ric8A is required for Gas pull down, strongly suggesting that
NCAM and Ric8A are part of a complex with Gas. Fourth,
NCAM180 enhanced b-adrenergic response by 1.75 fold, in an
entirely Ric8A dependent manner (Fig. 5A). Finally, inhibition of
Ric8A decreased b-adrenergic response more efficiently in the
presence of NCAM180 than in its absence, whereas this
observation was not made for the two other NCAM isoforms
(Fig. 5D), supporting the specific functional link between Ric8A
and NCAM180.
NCAM-Ric8A interaction modulates b-adrenergic
response in hippocampal neurons
To investigate the role of Ric8A in cells that endogenously express
NCAM180, we compared isoproterenol induced b-adrenergic
response in hippocampal neurons by measuring P-ERK (Fig. 5E)
and cAMP production in wild type and NCAM deficient neurons
(Fig. 5F). P-ERK induction by isoproterenol normalized for actin
from NCAM
2/2 was 32% that of NCAM
+/+ neurons. This
difference was abolished when Ric8A was inhibited (Fig. 5E).
Moreover, whereas 1 mM isoproterenol increased cAMP by 2.25-
fold in NCAM
+/+ neurons, this induction was significantly lower
(1.68-fold; p,0.01) when Ric8A was inhibited by siRNA (Fig. 5F)
indicating that Ric8A also potentiates b-adrenergic response in
neurons. Basal cAMP levels were however identical in non-treated
NCAM
+/+ and NCAM
2/2 neurons (NCAM
+/+/siCtrl: 4.48+/
20.74 nM; NCAM
+/+/siRic8A: 5.83+/20.95 nM; NCAM
2/2/
siCtrl: 3.01+/20.18 nM; NCAM
2/2/siRic8A: 4.06+/20.82 nM
in a representative experiment out of 3 performed). In addition,
1 mM (Fig. 5F) or 10 mM (not shown) isoproterenol was unable to
induce a significant production of cAMP in NCAM
2/2 neurons in
the presence or absence of Ric8A. These results indicate that in
neurons, NCAM is required for a b-adrenergic response, and this
requirement is at least partly dependent on Ric8A.
Discussion
In this study, a novel interactor of NCAM, Ric8A was
identified. We report an interaction between NCAM180 and
Ric8A. In contrast to NCAM120 and NCAM140, NCAM180
colocalized with Ric8A and specifically induced trafficking of
Ric8A from the cytoplasm to the membrane, and particularly to
DRM. Earlier observations reported a specific interaction of
NCAM180cyto with b spectrin [31]. However, a direct interaction
was later shown to occur also with NCAM140 [32]. The two-
hybrid data, together with biochemical and immunocolocalization
analysis suggest that Ric8A may interact preferentially with the
cytoplasmic domain of NCAM180.
Functionnally, our results showed that in HEK293T cells,
Ric8A potentiates a b-adrenergic response, that NCAM180,
Ric8A and Gas form a molecular complex, and that NCAM180
enhances b-adrenergic response only in the presence of Ric8A,
without modulating basal cAMP homeostasis. Moreover, consti-
tutive NCAM expression in hippocampal neurons is required to
induce cAMP production upon agonist stimulation, and a NCAM-
Ric8A interaction is potentially involved in b-adrenergic response
in the brain.
These results point to the role of constitutively expressed
NCAM and Ric8A in neurons and reveal an unsuspected
NCAM180 specific function in modulating a crucial intracellular
step in Ga-dependent signaling pathways. Ric-8 has previously
been shown to be a GEF for Gas in Xenopus [33], and
mammalian Ric8A to interact with Gas [34]. However, Tall et
al [6] did not show binding of Gas to rat Ric8A by yeast two-
hybrid screen. This discrepancy could be explained by the fact that
interaction in yeast does not take into account posttranslational
modifications predicted for Ric8A protein [6]. Hein et al [35]
showed that Gas activation is the rate-limiting step of GPCR
response. Therefore, NCAM180, by interacting with the Gas
signal amplifier Ric8A, and forming a tripartite complex with Gas
and Ric8A, could increase the rate of activation of Gas and/or
increase the availability of these effectors to the appropriate
subcellular compartments for signaling. DRM enriched in lipid
rafts play a crucial role in sorting mechanisms of receptors and
effectors involved in signaling [36]. Specifically, Gas localization in
Figure 4. Ric8A is not involved in NCAM induced cortical
neurite outgrowth. Embryonic mice cortical neurons were plated on
poly-D-lysine alone or in combination with PSA-NCAM-Fc. Non
transfected neurons, or neurons transfected with siCtrl or siRic8A were
either not treated or PSA-NCAM-Fc treated. After 3 days in culture,
neurons were stained with calcein as described in Materials and
Methods, and neurite length was quantified using the Metamorph
software. Data are from a representative experiment (out of 5
performed) and are expressed as mean +/2 SEM. One-way ANOVA
for more than 2 groups was performed. The effect of PSA-NCAM-Fc
treatment, was then analysed by with the Bonferroni post-hoc test.
doi:10.1371/journal.pone.0032216.g004
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e32216Figure 5. NCAM180 regulates b-adrenergic response via Ric8A in HEK293T cells and neurons. A- Representative experiment (out of 3
performed) of isoproterenol (10 mM) induced cAMP production in HEK293T cells transfected or not with NCAM180, in the presence (siCtrl) or absence
(siRic8A) of Ric8A. Data are expressed as mean +/2 SEM of 3 independent wells and analyzed by ANOVA and Bonferroni post-hoc test. B- Increase of
cAMP production by Ric8A overexpression in HEK293T cells transfected for 48 h with Ric8A-GFP (&) or PmaxGFP (X). Data are expressed as mean +/2
SEM of 3 independent wells and analyzed by the t-test. C- HEK293T cells were transfected with NCAM180, and control or Ric8A siRNA for 24 h. Anti-
NCAM beads were used for immunoprecipitation of cell extracts, A Western blot with anti-NCAM (first box) indicates that NCAM180 has been
immunoprecipitated. A Western blot was also performed with anti-Gas on each extract before immunoprecipitation to check the amount of loaded Gas
(second box). Anti-Gas (third box) and anti-Ric8A (fourth box) were used on NCAM180 immunoprecipitated extracts and show that Ric8A is significantly
decreased by siRic8A compared to siCtrl, and that Gas is immunoprecipitated when Ric8A is present (siCtrl).. D- Amount of cAMP generated by
isoproterenol (10 mM) that led to maximal efficacy in HEK293T, or HEK293T cells transfected with the different NCAM isoforms in the presence (siCtrl) or
absence (siRic8A) of Ric8A. Data are expressed as % of siCtrl transfected cells and as mean +/2 SEM of at least 3 independent experiments. Data were
analyzed by ANOVA for more than 2 groups and Bonferroni post-hoc test. E- P-ERK1/2 induction by isoproterenol (10 mM) in hippocampal neurons from
NCAM +/+ and 2/2 E15.5 embryos, in the presence (siCtrl) or absence (siRic8A) of Ric8A. Actin was used as constitutive protein. F- Amount of cAMP
produced by NCAM
+/+ and NCAM
2/2 non treated hippocampal neurons or after treatment with 1 mM isoproterenol in the presence (siCtrl) or absence
(siRic8A) of Ric8A. Data are expressed as percentage of non-treated neurons (mean +/2 SEM of 3 independent cultures). One-way ANOVAfor more than
2 groups was performed. The effect of the single factor ‘isoproterenol treament’ was then analysed by the Bonferroni post-hoc test.
doi:10.1371/journal.pone.0032216.g005
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Moreover, Ric8A controls Ga localization required during
asymetric division [7–9]. We showed that NCAM180 expression
was specifically associated with the anchoring of Ric8A at the
membrane and its enrichment in the DRM subdomains in
cultured cells and in vivo, in mouse brain. In brain, the relative
presence of Ric8A in DSM and DRM subdomains was directly
proportional to the amount of NCAM expressed. Interestingly, the
percentage of membranous Ric8A in DRM is similar following
NCAM180 overexpression in COS-7 cells (40%) and HEK293T
cells (46%), or in NCAM expressing brain (44%), supporting the
robustness of the observation in different systems. It is known that
NCAM180 is present in both DRM, particularly lipid rafts, and
DSM [32,37], thus the interaction of NCAM180 and Ric8A can
likely occur in DRM as well as in DSM. A possibility is that factors
such as spectrin may interact with NCAM180 in DSM [31] to
prevent or limit its interaction with Ric8A. Cooperative or
antagonistic factors may control the localization of Ric8A to
membrane subdomains NCAM180 being one of them. Indeed, if
NCAM180 was the only factor, NCAM would be required for
Ric8A localization in DRM and it would be absent from this
compartment in NCAM knock out brains, which is not the case
(Fig. 3D). Collectively, our findings lead us to propose that
NCAM180 promotes the translocation of part of Ric8A to DRM,
thereby amplifying b-adrenergic signaling locally in lipid rafts, thus
resulting in an enhanced cAMP production. They open the way to
investigations of other important events in the nervous sytem, such
as long term potentiation in the dentate gyrus which requires
NCAM [38] and depends on the activity of b-adrenergic receptors
[39].
Interestingly, in neurons, which specifically express NCAM180,
the proposed mechanism may intervene in neurotransmitter
release for which NCAM180 and Ric8A are known to be required
[11,13,14].
The extent to which the NCAM180-Ric8A interaction plays a
role in other GPCRs signaling remains to be explored, as
suggestions from other studies allow anticipating a more
generalized role. Indeed, although the Ric8A null mutation is
lethal, Ric8A heterozygous mice are viable and display some
functional overlap with NCAM null mice, such as an anxious
behavior. The anxious phenotype in NCAM knock out mice has
been partly associated with an increased sensitivity to 5HT-1A
agonist [16]. Moreover, expression of the NCAM180 in NCAM
knock out mice was sufficient to rescue the behavioral and
pharmacological phenotypes [17]. In summary, our data strength-
en the fact that NCAM functions as a signaling molecule, but also
demonstrate a novel role as a modulator of major signaling
pathways in the cell. This is a previously unidentified mechanism
of regulation of GPCR activity by a cell adhesion molecule, and
may represent a potential therapeutic target.
Supporting Information
Figure S1 Specificity and efficacy of Ric8A knock down
by small interfering RNA. A- Typical image of COS-7 cells
co-transfected with human Ric8A-GFP plasmid and siCtrl (a) or
siRic8A (b), or co-transfected with pCXmb-Cherry plasmid and
siCtrl (c) or siRic8A (d). Human Ric8A (green) was strongly
reduced by siRic8A whereas Cherry (red) was not affected. Scale
bar: a, b: 100 mm; c, d: 50 mm. B- Inhibition of endogenous Ric8A
by siRic8A in HEK293T cells and HEK293T transfected with
NCAM180 using a-tubulin constitutive protein as a reference. C-
Quantitative analysis of Western blot illustrated in B using the
ImageQuant software (Amersham Biosciences) as described
previously (Marino et al, 2009).
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